Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer

University Hospital, Brest460 enrolled

Overview

Auto-takings by APU and vaginal APV during the consultations for FCU in the department of gynecology-obstetrics (Group 1) according to an instructions for use proposed to the inclusive women, with consent; the same proposal, APU and APV, is made for other consultations requiring a screening on the CHRU (Group 2: dermatology, endocrinology, ambulatory surgery, inner medicine, pneumology, oncology). Auto-takings transmitted in the laboratory of the CHRU of Brest for test HPV by quantitative real-time PCR. Results transmitted to the women and to the doctors of consultation. In case of positive test (15 %), the patients are directed to a gynecologist. Confrontation with the cytological data when available (Group 1) .

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

460

Conditions

Research Human Papillomavirus ( HPV) by Vaginal Auto-takings ( APV) and Urinary Test

Interventions

Eligibility

Sex: FEMALEMin age: 25 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All the 25-65-year-old women requiring a screening and seen in consultation of the departments targeted by the CHRU of Brest Exclusion Criteria: * Women except age limit, refusal to participate, hysterectomy, pregnancy and post-therapeutic follow-up.

Outcomes

Primary Outcomes

Research for human Papillomavirus by vaginal auto-takings and urinary test

Estimate the research for human Papillomavirus ( HPV) in the vaginal auto-takings ( APV) and urinary ( APU) test at women from 25 to 65 years old requiring a screening.

Time frame: 6 months

Secondary Outcomes

The global logistic of the study

Estimate the practicability, the organization of the screening, the follow-up of the women at the Brest Hospital and at Landerneau Hospital